CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to evaluate the safety, tolerability and potential
effectiveness of CONCERTA® (methylphenidate hydrochloride extended-release tablets), a
central nervous system (CNS) stimulant for the treatment of adults with Attention Deficit
Hyperactivity Disorder (ADHD).